Oxford Drug Design raises £2.2M to develop AI-based drug discovery programme
Biotechnology agency Oxford Drug Design Restricted (ODD) has raised £2.2M in funding from present buyers ACF Traders, o2h Ventures, Meltwind Advisory, a number of returning angels and new buyers and the US-based R42 Group.
The Oxford College spinout has created a synthetic intelligence (AI) AI proprietary platform for drug discovery, targeted on unmet therapeutic wants in oncology.
Alan D Roth, CEO, ODD, mentioned: “This newest funding will allow us to construct on and speed up our profitable computational design-led discovery focus. We’re excited to be enjoying a pivotal function within the innovation of oncological remedies main to higher outcomes for most cancers sufferers worldwide.”
Rune Labs launch Portuguese subsidiary to enhance diabetes care
Precision neurology software program and knowledge platform firm Rune Labs has introduced the creation of a crew of lead designers based mostly in Lisbon, Portugal.
The brand new crew shall be targeted on increasing options and workflows for Rune Labs’ StrivePD ecosystem for Parkinson’s care. The subsidiary may even be Rune’s first everlasting presence in Europe.
Will Newby, VP of product, Rune Labs, mentioned: “Rune Labs is targeted on enabling human-centred care to individuals dwelling with Parkinson’s, and the Portugal crew of product designers will be sure that sufferers, clinicians, and researchers have a voice in our merchandise.”
Babylon GP at Hand opens two new clinics in London
Babylon GP at Hand has opened two new clinics in London that may present sufferers with face-to-face appointments alongside its digital-first built-in care.
The primary clinic in Dean Farrar Road, Victoria, opened final week and shall be adopted by a clinic in Drummond Road, Euston, subsequent month.
Dr Matthew Noble, UK medical director, Babylon, mentioned: “In-person care is so essential alongside highly-accessible digital appointments and we’re actually excited to launch these two new clinics for our Babylon GP at Hand sufferers in London.”
CDP Enterprise Capital launches digital well being startup accelerator
CDP Enterprise Capital Sgr has introduced the launch of an accelerator for digital well being startups, with a deal with progressive options for respiratory ailments, ophthalmology, ladies’s well being, uncommon ailments and power ache administration.
The VITA programme has been arrange along with Healthware Group and Danish accelerator Accelerace with complete belongings underneath administration of Є6.35 million.
Roberto Ascione, CEO and founder, Healthware Group, mentioned: “The VITA accelerator is testomony to Healthware’s dedication to contributing to the digital well being transformation, supporting the expansion and growth of essentially the most promising startups.”
Functions are open to Italian startups and worldwide startups aspiring to arrange registered places of work in Italy, till 12 June.
Medical trial finds blood take a look at can establish 79% of early-stage bowel most cancers
A major care medical trial in West Wales discovered {that a} blood take a look at was capable of choose up 79% of early-stage bowel cancers and 100% of superior bowel cancers.
The Raman Spectrometry (RS) blood take a look at was developed by Swansea College spin-out CanSense, with funding from Most cancers Analysis Wales and Well being and Care Analysis Wales.
CanSense have additionally secured £1.2 million from the Nationwide Institute for Well being and Care Analysis (NIHR) to additional develop the blood take a look at to make use of in medical apply throughout Wales.
Dr Cerys Jenkins, cofounder and director, CanSense, mentioned: “Having this take a look at obtainable on the triage stage would save time, cash, however most significantly save the sufferers from nervousness and pointless diagnostic assessments.”
AI most cancers diagnostics firm wins life science innovation award
British AI startup Behold.AI has gained Finest UK Digital Well being Answer on the Prix Galien awards.
The agency was awarded for its purple dot® medical evaluation software program for detecting lung most cancers from X-rays, which is in use at a number of NHS hospital websites as a part of an unbiased validation on affected person knowledge.
Simon Rasalingham, CEO and chairman, Behold.AI, mentioned: “The peer-reviewed proof we’ve constructed up exhibits that if we roll this know-how out nationally we are able to add within the equal of 233 NHS advisor radiologists, which is equal to 255,000 hours of advisor time per yr.”
